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Background: Latent tuberculosis infection (LTBI) relies on a homeostasis of macrophages and Mycobacterium
tuberculosis (Mtb). The small heat shock protein, Mtb Hsp16.3 (also known as latency-associated antigen), plays an
important role in Mtb persistence within macrophages. However, the mechanism of LTBI remains elusive. The aim
of this study was to delineate LTBI-related miRNA expression in U937 macrophages expressing Mtb Hsp16.3 protein.
U937 macrophages were infected with an integrase-deficient Lentivirus vector to transiently express Mtb Hsp16.3,
and green fluorescent protein (GFP) as a control. We used a microRNA (miRNA) microarray chip containing more
than 1000 probes to identify the significant differentially expressed miRNAs in the infected U937 cells, and
employed real-time quantitative polymerase chain reaction (qRT-PCR) for validation. Furthermore, we confirmed
these candidate LTBI-related miRNAs in peripheral blood mononuclear cells from subjects with LTBI and in healthy
control individuals. Functional annotation prediction of miRNA target genes and pathway enrichment analyses were
used to explore the putative links between these miRNAs and LTBI.
Results: Analysis of the miRNA expression profile identified 149 miRNAs that were differentially expressed in U937
macrophages expressing Mtb Hsp16.3 compared with the control expressing GFP. The expression level of seven
miRNAs (miR-424-5p, miR-493-5p, miR-296-5p, miR-27b-3p, miR-377-5p, miR-3680-5p, miR-191-5p) were validated by
qRT-PCR. The expression level of four miRNAs (miR-424-5p, miR-27b-3p, miR-377-5p, miR-3680-5p) in the peripheral
blood mononuclear cells samples from LTBI and healthy participants reflected the altered patterns observed in the
microarray profile. The bioinformatic analyses suggest that the miRNAs may regulate Mtb latent infection by
affecting the development of macrophage cells.
Conclusions: The results suggest that miRNA expression may play a considerable role in the pathogenesis of LTBI,
and this would increase our understanding of the molecular basis of Hsp16.3-facilitated Mtb survival in
macrophages.
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In the latent tuberculosis infection (LTBI) state, the
patient harbors the Mycobacterium tuberculosis (Mtb)
bacilli in the body and is asymptomatic; no radio-
graphic or bacteriological evidence of active tubercu-
losis is observed; however, the patients reveal
immunological sensitization to Mtb-derived antigen
proteins (e.g., ESAT6, CFP10, and Hsp16.3) [1]. The
granuloma is thought to play a major role in main-
taining latency and avoiding reactivation of Mtb,
representing the intersection of innate and adaptive
immunity. The hypoxic core of the granuloma is
thought to induce a dormant state of Mtb. In this re-
gard, in vitro studies have confirmed that Mtb dra-
matically upregulated dormancy survival regulon
(DosR)-related genes, which are characteristic of non-
replicating persistence [2]. One of the most promin-
ent of these is Rv2031c, which encodes the small heat
shock protein Hsp16.3 (also known as α-crystalline
related protein 1, or the 16 kDa antigen). Hsp16.3
constitutes one of the prominent antigens in the ex-
ponential phase after infection. It contains both T-
and B-cell epitopes that contributes to enhance the
cellular and humoral immune responses [3]. Interest-
ingly, Hsp16.3 is maximally expressed during latency,
play a role in facilitating the persistence of Mtb
within macrophages [4]. Indeed, the functional versa-
tility of macrophages is evident from their role in di-
verse biological processes, such as phagocytosis,
inflammation, immunoregulation, differentiation, and
metabolism [5]. Recent studies of these cells using
system biology and a variety of -omics technologies in
several disease models (e.g., atherosclerosis and meta-
bolic disorders) suggest that they orchestrate crucial
functions during homeostasis or pathogenesis in
health/disease [6].
MicroRNAs (miRNAs) are endogenous, 22–25 nucleo-
tide RNAs that play major regulatory roles in higher eu-
karyotes by targeting mRNAs for cleavage or translational
repression. MiRNAs modulate the innate and adaptive im-
mune responses to pathogens by affecting host immune cell
differentiation and progression of diseases [7]. The clinical
application of miRNAs as diagnostic or prognostic bio-
markers has already been demonstrated in various types of
cancers [8]. However, compared with their well-known role
in cancer, the biological and diagnostic role of miRNAs in
LTBI is still poorly understood. In the present study, we
used U937 cell line as in vitro macrophage model, focused
on the interaction between U937 macrophages and Mtb
Hsp16.3, aiming to identify differentially expressed miRNAs
in U937 macrophages. Our study intends to explore the po-
tential function of miRNAs in the interaction of macro-
phages with Mtb Hsp16.3 and provide insights for
investigating the role of macrophage homeostasis in LTBI.Methods
Ethics statement and participants
The local ethics committee of the Beijing Tuberculosis
and Thoracic Tumor Research Institute reviewed and
approved the study. Written informed consent was ob-
tained from participants before their enrollment in the
study. Twenty clinical health care workers of Beijing
Chest Hospital were recruited and all have history of
close contact with active tuberculosis patient for more
than two years. The four healthy controls were students
of Suzhou Institute of Biomedical Engineering and Tech-
nology and had no history of contact with TB. Potential
study participants were excluded if they had another in-
fectious disease. The interferon gamma release assay
(IGRA) (T-SPOT.TB, Oxford Immunuotec, Oxfordshire,
UK) was used to distinguish the LTBI group from
healthy control. Fourteen clinical health care worker par-
ticipants were IGRA-positive and included as LTBI
group while the four healthy control subjects were
IGRA-negative.
PBMC samples preparation
Peripheral venous blood (10 ml) was drawn from each
subject and PBMC samples were isolated by density gra-
dient separation using Lympholyte-H, immediately
mixed with TRIzol (1 ml) and frozen at −80°C until
RNA were extracted.
Preparation of the IDLV and Infection
To obtain the Mtb Hsp16.3 expression vector pLVHsp-
IRES-GFP, the encoding gene Rv2031c was amplified
and cloned into the pLVX-IRES-GFP plasmid, and con-
firmed by sequencing. The Lenti-X HTX Packaging Sys-
tem (Integrase Deficient) (Clontech, Mountain View,
CA, USA) was used to prepare the viral vector. The
U937 cells were cultured in RPMI1640 medium (Gibco,
Grand Island, NY, USA) containing 10% fetal bovine
serum under 5% CO2 at 37°C, infected with viral IDLVs
stock at 5:1 multiplicity of infection (MOI), refreshed
with medium 6 h later and incubated for 64 h.
Western blot analysis
Briefly, U937 cells were infected with IDLVs (Hsp/GFP),
and control IDLVs (GFP), respectively. After 64 h, the
cells were collected and then heated for 5 min at 95°C in
1 × protein loading buffer containing β-mercaptoethanol,
and cell extracts were separated on 12% SDS-PAGE gel
and transferred to PVDF membranes. The membranes
were blocked with 5% skimmed milk-TBST, incubated
with polyclonal rabbit anti-Mtb Hsp16.3 antibodies
(prepared in our laboratory) and β-actin antibodies
(Solarbio, Beijing, China), and finally visualized via reac-
tion with a chemiluminescent HRP substrate (Millipore,
Billerica, MA, USA).
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KangCheng Biosciences (Shanghai, China) performed the
miRNA profiling analysis. To determine the miRNA pro-
files for the two groups, total RNAs were purified using
TRIzol (Invitrogen, Grand Island, NY, USA) and a miR-
Neasy mini kit (Qiagen, Shenzhen, China), labeled using
the miRCURY™ Hy3™/Hy5™ Power labeling kit (Exiqon,
Vedbaek, Denmark) and hybridized on the specific miR-
CURY™ LNA Array (v.18.0, Exiqon, Denmark) platform.
The Exiqon miRCURY™ LNA Array (v.18.0) contains 2043
capture probes covering all human miRNAs, and could
quantify genome-wide miRNA expression in the two
groups. Images on the chip were scanned using an Axon
GenePix 4000B microarray scanner (Axon Instruments,
Foster City, CA, USA) and imported into GenePix Pro 6.0
software (Axon) for grid alignment and data extraction.
MiRNAs with intensities >50 were used to calculate the
normalization factor. Expression data were normalized
using the median normalization. After normalization, aver-
age values of replicate spots of each miRNA were used for
statistical analysis; differentially expressed miRNAs were
identified through fold change filtering. Data are presented
as means ± standard deviations. Analysis of variance tests
or unpaired two-tailed Student t tests were used for statis-
tical analysis. The data were regarded as significantly differ-
ent at P < 0.05.Figure 1 The integrase-deficient lentivirus vector (IDLV) transfected U
Hsp16.3. An IDLV delivered the transgene into U937 macrophages for inst
cytometry were used at 64 h after infection to detect GFP and analyse the
of U937 cells (expressing Mtb Hsp16.3 and GFP) was 73%. B, the transducti
western blot analysis with antibodies against Mtb Hsp16.3; β-actin was useReverse transcription and quantitative real time-
polymerase chain reaction (qRT-PCR) validation
The total RNAs were extracted from each two groups
of infected U937 macrophages and PBMC samples
using a mirVana™ miRNA Isolation Kit (Ambion,
Austin, TX, USA). cDNA was reverse transcribed
from total RNAs using the miRcute miRNA cDNA
first-strand synthesis kit (Tiangen, Beijing), according
to the manufacturer’s instructions. Using U6/5S RNA
as the endogenous reference for normalization, qRT-
PCR assays were performed on an ABI 7500 Real-
Time PCR System (Applied Biosystems, Foster, CA,
USA) using the miRcute miRNA qPCR Detection kit
(SYBR Green) (Tiangen, Beijing, China). The experi-
ments were conducted in triplicate.Pathway enrichment analyses
The predicted targets of the miRNAs were obtained
from the TargetScan database [9], and the PITA database
[10]. The intersections of the results obtained from these
different software programs were regarded as the reliable
target genes. The predicted miRNA target genes were
analyzed for enriched KEGG pathways using the NCBI
DAVID server (http://david.abcc.ncifcrf.gov) with default
settings [11].937 cells with high efficiency and the cells expressed Mtb
antaneous expression. The fluorescence microscopy and flow
transduction efficiency. A, the transduction efficiency of the test group
on efficiency of the control group (expressing GFP only) was 82%. C,
d as a loading control.
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U937 Macrophages expressed Mtb Hsp16.3 and GFP,
respectively
To reduce the risk of insertional mutagenesis in U937
cells, the IDLV system was used to produce non integra-
tive lentiviral vectors , which delivered the transgene
into U937 macrophages for instantaneous expression.
After 64 h, the fluorescence microscopy was used to de-
tect the GFP expression, and GFP-positive cells was
quantified by the flow cytometry. It was shown that the
transformation efficiency of the test group of U937 cells
(expressing Mtb Hsp16.3) was 73% (Figure 1A), and that
of the control group (expressing GFP) was 82%
(Figure 1B). Furthermore, to validate the expression of
Mtb Hsp16.3 protein in the cells, western blot analysis
was performed using anti-Mtb Hsp16.3 and the resultsTable 1 Summary of upregulated miRNAs
Name Fold change P value Chr. Loc.
hsa-miR-2355-3p 2.00 0.00162 2
hsa-miR-451a 2.20 0.01085 17
hsa-miR-130b-3p 2.30 0.04627 22
hsa-miR-486-5p 2.32 0.00208 8
hsa-miR-361-5p 2.33 0.04722 X
hsa-miR-3156-3p 2.50 0.00729 10
hsa-miR-4728-3p 2.67 0.00029 17
hsa-miR-3191-5p 2.67 0.00020 19
hsa-miR-296-5p 2.71 0.04951 20
hsa-miR-150-5p 2.85 0.00927 19
hsa-miR-4540 2.86 0.01280 9
hsa-miR-4268 2.97 0.00969 2
hsa-miR-1236 3.08 0.04877 6
hsa-miR-221-5p 3.16 0.03132 X
hsa-miR-3685 3.26 0.00356 12
hsa-let-7d-3p 3.35 0.02153 9
hsa-miR-3941 3.39 0.00646 10
hsa-miR-498 3.47 0.0484 19
hsa-miR-548as-3p 3.49 0.00657 13
hsa-miR-323a-3p 3.70 0.00350 14
hsa-miR-550a-3p 3.71 0.00074 7
hsa-miR-30e-3p 3.75 0.01335 Unknown
hsa-miR-1273e 3.83 0.00201 Unknown
hsa-miR-200b-3p 3.83 0.00148 1
hsa-miR-2113 4.02 0.01267 6
hsa-miR-615-3p 4.03 0.00110 12
hsa-miR-33b-5p 4.07 0.02481 17
hsa-miR-147b 4.18 0.00080 15
hsa-miR-7-2-3p 4.29 0.00900 15
hsa-miR-657 4.30 0.00035 17demonstrated that Mtb Hsp16.3 was strongly expressed
in the test group of U937 cells (Figure 1C).
Expression profiles of miRNAs in U937 cells from the test
group and the control group
To determine the miRNA profiles for the two groups,
the Exiqon miRCURY™ LNA Array was employed to
perform the 2043 miRNAs assay (1898 human and 145
human viral miRNAs represented in the Sanger miRBase
v18.0). After normalization and unsupervised filtering
(see Methods), the obtained average values for each
miRNA spot were used for statistical analysis. Compar-
ing the data from the two groups (test/control) and
using fold change filtering (upregulated more than 2-
fold and downregulated less than 0.5-fold ), total of 149
differentially expressed miRNAs was identified, of whichName Fold change P value Chr. Loc.
hsa-miR-133b 4.30 0.00992 6
hsa-miR-4664-3p 4.31 0.00022 8
hsa-miR-4431 4.35 0.00368 2
hsa-miR-4804-3p 4.36 0.00023 5
hsa-miR-18b-3p 4.62 0.00191 X
hsa-miR-675-3p 4.68 0.00028 11
hsa-miR-550b-3p 4.72 0.01382 7
hsa-miR-551a 4.75 0.00063 1
hsa-miR-4685-3p 5.04 0.00090 10
hsa-miR-23c 5.11 0.00081 X
hsa-miR-5002-3p 5.14 0.00035 3
hsa-miR-5689 5.33 0.00054 6
hsa-miR-935 5.43 0.00187 19
hsa-miR-374b-3p 5.79 5.4E-05 X
hsa-miR-1255b-2-3p 5.83 0.00823 1
hsa-miR-485-3p 6.00 0.00085 14
hsa-miR-3938 6.03 0.00821 3
hsa-miR-374c-3p 6.04 0.00125 X
hsa-miR-377-5p 6.29 0.00024 14
hsa-miR-4324 6.39 0.00669 19
hsa-miR-4436b-5p 6.56 9.0E-05 2
hsa-miR-1184 6.64 0.00266 X
hsa-miR-5690 7.22 6.6E-05 6
hsa-miR-125b-2-3p 7.68 0.00145 21
hsa-miR-4511 8.40 0.00580 15
hsa-miR-548ao-3p 9.50 6.4E-05 8
hsa-miR-224-3p 13.23 0.00314 X
hsa-miR-4278 14.61 9.4E-05 5
hsa-miR-3680-5p 20.93 0.00474 16
hsa-miR-4678 31.50 0.00070 10
Table 2 Summary of downregulated miRNAs
Name Fold change P value Chr. Loc. Name Fold change P value Chr. Loc.
hsa-let-7a-5p 0.038 1.1E-05 9 hsa-miR-3651 0.312 0.00422 9
hsa-miR-27a-3p 0.050 0.00148 19 hsa-miR-19a-3p 0.312 0.04552 13
hsa-miR-378c 0.053 0.00035 10 hsa-miR-106b-5p 0.315 0.00649 7
hsa-miR-3175 0.061 0.00039 15 hsa-miR-375 0.316 0.00187 2
hsa-miR-30a-5p 0.069 0.00115 6 hsa-miR-1973 0.326 0.00071 4
hsa-miR-374a-5p 0.078 0.00085 X hsa-miR-4695-3p 0.331 5.7E-05 1
hsa-let-7f-5p 0.083 0.00068 9 hsa-miR-4279 0.335 0.00114 5
hsa-miR-424-5p 0.083 0.00112 X hsa-miR-3182 0.342 0.00749 16
hsa-miR-16-5p 0.089 0.00715 13 hsa-miR-4454 0.342 0.00115 4
hsa-miR-181a-5p 0.106 0.04102 9 hsa-miR-4644 0.358 0.00413 6
hsa-miR-25-3p 0.129 0.00012 7 hsa-miR-197-3p 0.359 0.00547 1
hsa-miR-4653-3p 0.129 0.00054 7 hsa-miR-15a-5p 0.362 0.03027 13
hsa-miR-146a-5p 0.140 0.00239 5 hsa-miR-2115-3p 0.364 0.00016 3
hsa-miR-339-5p 0.146 0.00248 7 hsa-miR-937 0.365 0.00801 8
hsa-miR-5089 0.156 0.00179 17 hsa-miR-331-3p 0.374 0.00109 12
hsa-miR-493-5p 0.163 0.00619 14 hsa-miR-374b-5p 0.380 0.01720 X
hsa-miR-652-3p 0.164 0.00214 X hsa-miR-1273 g-3p 0.382 0.00549 1
hsa-miR-21-5p 0.165 0.00059 17 hsa-miR-4668-5p 0.386 0.00013 9
hsa-miR-142-5p 0.175 0.00056 17 hsa-miR-20b-3p 0.390 0.01073 X
hsa-miR-3653 0.178 0.00117 22 hsa-miR-148a-3p 0.391 0.00075 7
hsa-miR-27b-3p 0.188 0.00133 9 hsa-miR-483-3p 0.392 1.4E-05 11
hsa-miR-299-3p 0.191 0.00112 14 hsa-miR-4450 0.393 0.00068 4
hsa-miR-1260a 0.193 7.5E-05 14 hsa-miR-93-5p 0.400 0.00736 7
hsa-miR-4445-5p 0.202 8.2E-05 3 hsa-miR-5684 0.405 0.00132 19
hsa-miR-301a-3p 0.207 0.00485 17 hsa-miR-4500 0.413 0.00962 13
hsa-miR-451b 0.210 0.00559 17 hsa-miR-3654 0.415 0.00400 7
hsa-miR-107 0.216 0.00010 10 hsa-miR-223-3p 0.416 0.00199 X
hsa-miR-196b-3p 0.226 0.00083 7 hsa-miR-3607-5p 0.421 0.00412 5
hsa-miR-5581-3p 0.229 9.8E-05 1 hsa-miR-93-3p 0.422 0.00129 7
hsa-miR-4417 0.230 0.00124 1 hsa-miR-24-3p 0.427 0.03788 9
hsa-miR-185-5p 0.239 0.01367 22 hsa-miR-365a-3p 0.433 0.00030 16
hsa-miR-1275 0.240 0.01379 6 hsa-miR-1260b 0.434 0.00267 11
hsa-miR-4636 0.241 0.00018 5 hsa-miR-4467 0.435 0.00152 7
hsa-miR-4787-5p 0.241 2.5E-05 3 hsa-miR-92b-3p 0.435 0.00053 1
hsa-miR-23b-3p 0.243 0.00758 9 hsa-miR-22-3p 0.436 0.01803 17
hsa-miR-30e-5p 0.244 0.04555 1 hsa-miR-1587 0.439 2.9E-05 X
hsa-miR-4286 0.254 3.0E-05 8 hsa-miR-142-3p 0.443 0.01233 17
hsa-miR-138-2-3p 0.256 0.00280 16 hsa-miR-26a-5p 0.448 0.00101 3
hsa-miR-29c-3p 0.260 0.01283 1 hsa-miR-644b-5p 0.458 0.01973 X
hsa-miR-4633-5p 0.261 0.00099 5 hsa-miR-15b-5p 0.460 0.03179 3
hsa-miR-7-5p 0.267 0.02246 15 hsa-miR-20b-5p 0.464 0.04709 X
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Table 2 Summary of downregulated miRNAs (Continued)
hsa-miR-660-5p 0.280 0.00851 X hsa-miR-4429 0.465 0.03150 2
hsa-miR-5000-3p 0.302 0.00034 2 hsa-miR-3646 0.470 0.00101 20
hsa-miR-30b-5p 0.303 0.00623 8 hsa-let-7d-5p 0.490 0.00531 9
hsa-miR-532-5p 0.309 0.00987 X
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lated (Table 2). The P values for these 149 miRNAs were
less than 0.05 in the test groups compared to results for
the control groups.qRT-PCR validation of candidate miRNA expression level
To validate the microarray findings, seven miRNAs were
selected for qRT-PCR analysis. The miR-424-5p (previous
ID: miR-424), miR-493-5p (previous ID: miR-493*), and
miR-296-5p were reported as potential to discriminate be-
tween latent TB and healthy by the previous study [12], the
other four miRNAs (miR-27b-3p, miR-377-5p, miR-3680-
5p, miR-191-5p) were randomly selected. As shown in
Figure 2A, the respective level of downregulated miR-27a-
3p, miR-424-5p, and miR-493-5p in qRT-PCR results
largely reflected the altered patterns of these selected miR-
NAs observed in the microarray profiles. In parallel, the
levels of upregulated miR-296-5p, miR-377-5p, miR-3680-
5p, and unchanged miR-191-5p were similar to the chip re-
sults as well (Figure 2B). Furthermore, to evaluated the rela-
tive expression level of the six differentially expressed
miRNAs in LTBI group and healthy control, 14 LTBI sub-
jects and four healthy control individuals were recruited for
the qRT-PCR assay (Additional file 1: Table S1). As shown
in Figure 3, the results of four miRNAs (miR-424-5p, miR-
27a-3p, miR-377-5p, miR-3680-5p) recapitulated the micro-
array data, and the other two miRNAs (miR-493-5p and
miR-296-5p) were not significant differentially expressed.Figure 2 Confirmation of miRNA expression profiles of the microarray
the relative expressions of selected downregulated miRNAs (miR-27a-3p, m
relative expressions of upregulated miRNAs (miR-296-5p, miR-377-5p, and m
in B.Bioinformatic exploratory analyses
Because only very small number of miRNA targets has
been experimentally validated so far, we predicted the tar-
gets of these differentially expressed miRNAs using Tar-
getScan and PITA software (Additional file 2: Table S2).
The identified miRNAs were predicted to modulate 7044
target genes. We then used the NCBI DAVID server to
identify the significantly enriched pathways involving the
predicted target genes. As shown in Table 3, apart from
cancer-associated pathways, the MAPK signaling, endo-
cytosis, Wnt signaling, focal adhesion, axon guidance, and
TGF-beta signaling pathways, which are related to differen-
tiation, polarization, and versatility of macrophages, were
significantly enriched. The results suggest that the miRNAs
may regulate Mtb infection by affecting the development of
immune cells.Discussion
The macrophage is the main replication niche of Mtb, des-
pite the bactericidal characteristics and functions that this
cell type normally has. The Mtb has evolved several strat-
egies to reside and even replicate within the otherwise
hostile environment of the macrophage, including the pre-
vention of phagosome-lysosome fusion, inhibition of
phagosomal maturation, and detoxification of the host’s
stresses. Accordingly, the localization of Mtb inside the
macrophage has been a matter of debate in recent years
[13]. For a long time, an impermeable phagosome in theby qPCR. After normalization to 1 in the control group (U937/GFP),
iR-424-5p, and miR-496-5p) in the test group are shown in A; the
iR-3680-5p), and unchanged miR-191-5p in the test group are shown
Figure 3 qPCR validation of miRNA expression levels in samples from the latent tuberculosis infection (LTBI) group versus the healthy
control group. Relative expressions of miR-424-5p, miR-496-5p, miR-27a-3p, miR-377-5p, and miR-3680-5p in LTBI and healthy samples. Statistical
analysis was performed using the unpaired t-test. **P < 0.01, *P < 0.05, NS: not significant.
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evidence indicates that Mtb, as well as M. leprae, can es-
cape its vacuole and reside in the host cell cytosol [14]. It is
becoming clear that LTBI is not a static state with a
homogenous population of non-replicating bacilli, but a
constant endogenous Mtb reinfection process [15]. It is ar-
gued that both phagosomal maturation inhibition and es-
cape from the phagosome are part of the survival strategies
of Mtb. Owing to the lack of widely accepted animal or
in vitro models to reflect the complex biology of LTBI,
population-based studies are considered the best methods
to investigate the intricate nature of LTBI. In some previous
reports, human cell line U937 was used as in vitro model to
investigate the molecular mechanism of Mtb during infec-
tion or persistence and its effect on the cell [16,17]. In this
study, U937 cells expressing Hsp16.3 in the cytosol could
partialy reflect the dynamic interplay of macrophages with
dormant Mtb, which is necessary to prevent reactivation of
the bacilli and development of active TB.
Indeed, some miRNAs that have been previously linked
to carcinogenesis of different organs and tissues, such as
miR-424-5p (previous ID: miR-424), miR-221-5p (previous
ID: miR-221*), miR-675, miR-647, miR-125a-5p, miR-214-
3p (previous ID: miR-214), miR-130b-3p (previous ID:
miR-130b), miR-522-3p (previous ID: miR-522), and miR-
16-5p (previous ID: miR-16) [18-21] were found to be up-or downregulated in our analysis. Forrest and colleagues
[22] showed that induction of miR-424 (miR-424-5p) and
miR-222 (miR-222-3p) promotes monocytic differentiation
via combined regulation; both of these miRNAs were sig-
nificantly downregulated in this analysis. Interestingly, miR-
150-5p (previous ID: miR-150) has been shown to regulate
the immune response and monocyte differentiation [23];
miR-150-5p was upregulated in our analysis. Conversely,
miR-181a (miR-181a-5p) and miR-146a (miR-146a-5p),
which have been proven to participate in the regulation of
the adaptive immune responses, were 7- and 10-fold down-
regulated in our profiling data [24,25]. Furthermore,
current research has demonstrated that miR-181a regulates
inflammation responses in macrophages, and increased ex-
pression of miR-181a is strongly correlated with the expres-
sion of interleukin (IL)-1β, IL-6, and tumor necrosis factor
alpha (TNFα) [26]. These results suggest that Hsp16.3 pro-
tein might be involved in blocking immunity against Mtb
via miR-181a and miR-146a deregulation. In addition, Fu
et al. demonstrated that miR-93*(miR-93-3p) was the most
upregulated in active TB serum [27]; however, our analysis
indicated that miR-93-3p was downregulated, making it a
potential diagnostic marker to distinguish latent TB from
active TB.
Although many target genes have been predicted by bio-
informatic methods, the functions of most differentially
Table 3 Enriched pathways involving the predicted target
genes
Pathway name p value
Pathways in cancer 5.60E-16
MAPK signaling pathway 1.70E-14
Endocytosis 6.90E-14
Neurotrophin signaling pathway 1.50E-13
Wnt signaling pathway 6.50E-13
Focal adhesion 7.60E-11
Axon guidance 1.10E-10
ErbB signaling pathway 7.10E-09
Glioma 5.80E-08
Basal cell carcinoma 6.20E-08
Long-term potentiation 6.30E-08
TGF-beta signaling pathway 9.10E-08
Regulation of actin cytoskeleton 1.10E-07
mTOR signaling pathway 3.70E-07
Adherens junction 1.30E-06
Chemokine signaling pathway 1.10E-05
Long-term depression 1.90E-05
T cell receptor signaling pathway 3.00E-05
Gap junction 5.60E-05
Fc gamma R-mediated phagocytosis 1.60E-04
B cell receptor signaling pathway 4.60E-04
GnRH signaling pathway 5.40E-04
Fc epsilon RI signaling pathway 7.60E-04
Phosphatidylinositol signaling system 1.50E-03
VEGF signaling pathway 1.50E-03
Vascular smooth muscle contraction 2.20E-03
SNARE interactions in vesicular transport 2.40E-03
ECM-receptor interaction 2.40E-03
Meng et al. BMC Microbiology 2014, 14:37 Page 8 of 9
http://www.biomedcentral.com/1471-2180/14/37expressed miRNAs remain unknown, and very few pre-
dicted target genes have been validated. More than half of
the differentially expressed miRNAs did not find a target
mRNA in either database; most of them were recently iden-
tified miRNAs. Bioinformatic exploratory provides a rapid
analytic approach categorizing large amounts of genes into
functionally related groups to thereby facilitate the uncover-
ing of the biological content captured by transcriptomic
profiling. KEGG pathway enrichment analyses further inter-
pret the biological functions of these genes. The overrepre-
sented pathways associated with glioma and basal cell
carcinoma were enriched, which somewhat surprised. The
formation of extra-pulmonary tuberculosis is caused by
Mtb dissemination to other organs or tissue, such as the
central nervous system (CNS) [28]. It is speculated that the
occurrence of glioma might be related to tuberculoma in
the CNS, and a tuberculoma-like granuloma is oftenmisdiagnosed as a tumor [29]. This indicated that Mtb
Hsp16.3 might be involved in carcinogenesis, which war-
rants further investigation.
Earlier studies, which used peripheral blood mononuclear
cells (PBMCs) or whole blood cells to perform whole gen-
ome transcriptional profiling and miRNA profiling [27,30],
described a number of candidate biomarkers that might
function in active TB. Wang and collegues identified miR-
NAs that were differently expressed in latent TB versus
healthy from the clinical PBMC samples [12], In present
study, the microarray data and independent qRT-PCR re-
sults indicated that our in vitro model by used of U937 cells
expressing Mtb Hsp16.3 protein has good repeatability.
However, the weakness of the model is also obvious, it does
not represent the real interaction of pathogen and host
macrophage in vivo, it provided only mechanistic insights
on the interaction between Mtb antigen and human cell
line. Although the expressions of miR-424-5p (previous ID:
miR-424), miR-27a-3p, miR-377-5p and miR-3680-5p were
consistent in clinical PBMC samples, the small size of
healthy controls weakened the statistical power. Our under-
standing the biology of latent tuberculosis as part of a broad
range of responses that occur following infection with Mtb
remains incomplete. Multiple factors are involved in this
complex process. Herein, compared to previously studies,
our experiments got more differentially expressed miRNAs
since we focused on just whether the Mtb Hsp16.3 had
great effects on the U937 macrophage cell. Furthermore,
this model could also be used in the follow-up investigation
of the miRNA candidates regulating the macrophage in
chronic inflammatory response or other process correlated
with LTBI.Conclusions
Using miRNA expression profiling, we identified 149 differ-
entially expressed miRNAs and validated that the transcrip-
tion patterns of some miRNAs were consistent with
previous reports. Our data provide evidences for the under-
lying biological processes involved in LTBI via the inter-
action between U937 macrophages and the Mtb Hsp16.3
protein. These findings provide an improved understanding
of the link between miRNA homeostasis and LTBI. Further
characterization of the pathogenetic roles of specific miR-
NAs and deciphering of the miRNA-controlled signaling
regulatory network may help to enhance diagnosis and pre-
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